RG
EPZM

Redmile Group’s Epizyme, Inc EPZM Stock Holding History

Redmile Group’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-454,475
Closed -$523K – 74
2022
Q1 		$523K Hold
454,475
– – 0.02% 70
2021
Q4 		$1.14M Sell
454,475
-7,004,185
-94% -$27.5M 0.03% 71
2021
Q3 		$38.2M Sell
7,458,660
-1,056,400
-12% -$6.42M 0.67% 43
2021
Q2 		$70.8M Sell
8,515,060
-309,306
-4% -$2.61M 1.05% 31
2021
Q1 		$76.9M Sell
8,824,366
-625,939
-7% -$6.48M 1.08% 34
2020
Q4 		$103M Buy
9,450,305
+1,138,672
+14% +$14M 1.24% 22
2020
Q3 		$99.2M Sell
8,311,633
-173,972
-2% -$2.33M 1.82% 12
2020
Q2 		$136M Sell
8,485,605
-282,870
-3% -$4.94M 2.52% 11
2020
Q1 		$136M Buy
8,768,475
+22,442
+0.3% +$482K 3.81% 8
2019
Q4 		$215M Buy
8,746,033
+109,100
+1% +$1.62M 5.15% 5
2019
Q3 		$89.1M Sell
8,636,933
-92,209
-1% -$1.16M 2.98% 10
2019
Q2 		$110M Buy
8,729,142
+1,035,122
+13% +$13.3M 3.1% 7
2019
Q1 		$95.3M Buy
7,694,020
+1,056,742
+16% +$11.8M 2.79% 10
2018
Q4 		$40.9M Buy
6,637,278
+4,389,089
+195% +$33.5M 1.64% 21
2018
Q3 		$23.8M Buy
2,248,189
+226,800
+11% +$2.59M 0.73% 46
2018
Q2 		$27.4M Buy
2,021,389
+9,400
+0.5% +$146K 0.93% 39
2018
Q1 		$35.7M Buy
2,011,989
+86,300
+4% +$1.46M 1.38% 28
2017
Q4 		$24.2M Buy
1,925,689
+715,689
+59% +$10.4M 1.05% 35
2017
Q3 		$23.1M Buy
+1,210,000
New +$18.5M 1.14% 31

Other funds holding EPZM

RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group's EPZM Position: Q2 2022 in Review

Redmile Group sold out of Epizyme, Inc (EPZM) in Q2 2022, closing a stake of 454,475 shares — an estimated $523K sold.

Redmile Group first reported a position in EPZM in Q3 2017 and held it in 19 quarters. The position peaked at $215M in Q4 2019. 93 funds tracked by Wall St. Rank hold EPZM as of Q2 2022.

  • Redmile Group reported no remaining Epizyme, Inc position as of Q2 2022 after selling out during the quarter.
  • Redmile Group sold 454,475 Epizyme, Inc shares in Q2 2022, an estimated $523K.
  • Redmile Group first reported a position in Epizyme, Inc in Q3 2017 and held it in 19 quarters.
  • Redmile Group's Epizyme, Inc position peaked at $215M in Q4 2019.
  • 93 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2022.

Based on Redmile Group's 13F filing for Q2 2022, filed 15 Aug 2022.